New drug aims to reverse deadly wasting in cancer patients
NCT ID NCT07112196
First seen Dec 10, 2025 · Last updated May 14, 2026 · Updated 20 times
Summary
This study tests a new drug called visugromab in about 518 people with advanced lung or bowel cancer who are losing weight unintentionally (cachexia). The goal is to see if the drug helps patients gain weight, improve appetite, and move better compared to a placebo. Participants receive the drug or placebo as a drip every 4 weeks at the clinic.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER-ASSOCIATED CACHEXIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cantonal Hospital St. Gallen (Kantonsspital St. Gallen)
RECRUITINGSankt Gallen, 9000, Switzerland
-
Léon Bérard Center (Centre Léon Bérard)
RECRUITINGLyon, 69008, France
-
Mid Florida Hematology and Oncology Centers
RECRUITINGOrange City, Florida, 32763, United States
-
Oslo University Hospital
RECRUITINGOslo, 0372, Norway
-
Specialized Hospital for Active Treatment in Oncology
RECRUITINGHaskovo, 6300, Bulgaria
-
University Hospital of A Coruña (Hospital Universitario de A Coruña)
RECRUITINGA Coruña, 15006, Spain
-
University Hospital of Zurich (Universitätsspital Zürich)
RECRUITINGZurich, 8006, Switzerland
Conditions
Explore the condition pages connected to this study.